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ABSTRACT
Background: Chlamydia trachomatis infection, being 
largely asymptomatic, is difficult to diagnose using the 
common diagnostic methods which have varying degrees 
of  sensitivity and specificity. There is a paucity of  data on 
the prevalence of  Chlamydia trachomatis infection in 
Nigeria. The aim of  this research is to determine the 
prevalence of  and predictive risk factors for Chlamydia 
trachomatis infection among female undergraduate 
students of  the University of  Port Harcourt.
Methods:  Four hundred undergraduate, non pregnant, 
asymptomatic female students below the age of  30 years 
were randomly selected and given questionnaires with self  
administrable vaginal swab sticks. The participants 
completed the questionnaires and provided vaginal swab 
samples which were analyzed using Strand Displacement 
and Amplification Technique.
Results:  Of  the 400 sexually active participants, 44 tested 
positive [prevalence rate of  11%] for Chlamydia 
trachomatis. Some of  the associated risks factors identified 
were, having multiple sexual partners especially in the last 
90 days, irregular contraceptive usage and past history of  
sexually transmitted infections.
Conclusion: There is an urgent need for a national policy 
on routine screening for Chlamydia trachomatis as 
treatment is cheap and effective, while the morbidity 
resulting from delayed diagnosis is more difficult to 
manage and associated with severe sequelae.
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challenge of  Chlamydia control remains the identification 
of  asymptomatic individuals. The inherent morbidity that 
results from asymptomatic Chlamydia trachomatis 
infection has necessitated the screening for Chlamydia 
trachomatis among women who are aged 25 years and 
5 6above ; unmarried, separated or divorced ; or with past 
7histories of  STI's ; or with new or multiple sexual partners 
8within the past 90 days  and; women who inconsistently 
9use barrier form of  contraception .
Although the major impact of  disease caused by 
Chlamydia trachomatis is on the female reproductive tract, 
this agent also causes infections in men and children. The 
prevalence of  Chlamydia infection in sexually active 
adolescent women, the population considered most at risk 
10generally exceeds 10% , and in some STI clinic 
10populations of  women, the prevalence can reach 40% . 
The prevalence of  Chlamydia trachomatis infection ranges 
from 4 to 10% in asymptomatic men and from 15 to 20% in 
11men attending STI clinics .
Although Chlamydia trachomatis can be easily treated 
with antibiotics, control of  the infection has been impeded, 
primarily because the symptoms of  the infection are often 
absent or insufficient to lead to diagnosis, especially among 
12many affected women . If  untreated, it may lead to severe 
sequelae ranging from pelvic inflammatory disease [PID], 
through tubal scarring to ectopic pregnancy and tubal 
7infertility . Also, about one-third of  women with untreated 
Chlamydial infection go on to develop PID, by ascending 
13infection  and PID is the predominant infectious cause of  
2,14,15chronic pelvic pain and tubal infertility . Chlamydial 
genital infection during pregnancy increases the risk of  
spontaneous abortion, premature delivery and ectopic 
pregnancy. Neonates delivered vaginally from infected 
mothers may contract Chlamydial conjunctivitis or 
14pneumonia . Chlamydial infections in newborns occur as 
a result of  perinatal exposure. It is known that about 65% of  
babies born from infected mothers become infected during 
16vaginal delivery .
Chlamydia trachomatis is a spherical or ovoid, non motile, 
gram negative, obligate, intra cellular bacterium thought 
initially to be a virus because of  the intracellular life cycle. It 
is metabolically deficient in its ability to synthesize ATP 
and thus requires an exogenous source of  this high energy 
compound. This is why it is called an energy parasite. It 
undergoes a unique biphasic developmental cycle, forming 
distinctive intracellular inclusions that permit 
identification by light or fluorescent microscopy. 
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INTRODUCTION
Genital Chlamydia trachomatis infection is the most 
common curable sexually transmitted infection [STI] 
1worldwide . Chlamydia trachomatis is the most prevalent 
bacterial cause of  STI in men and women worldwide, with 
2,3about 50 million new infections yearly . It mostly runs an 
4 5asymptomatic course in women  and men , therefore it 
remains undetected and subsequently untreated. While the 
6main burden of  morbidity falls upon women , the 
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Chlamydia trachomatis is susceptible to a broad spectrum of  
antibiotics, particularly the tetracyclines and macrolides. 
Because the Chlamydial cell wall is different from that of  
many bacteria, beta-lactam antibiotics such as penicillin lack 
bactericidal activity against these microorganisms. 
Chlamydia trachomatis includes the agents of  trachoma, 
lymphogranuloma venereum [LGV], urogenital tract disease, 
and inclusion conjunctivitis. 
Strand Displacement and Amplification [SDA] technique is a 
form of  Nucleic Acid Amplification Technique [NAAT] with 
a high specificity and sensitivity in the diagnosis of  
20,21Chlamydia trachomatis infection . The technique allows 
for the use of  not only urine but also self  administered vaginal 
swab as the clinical specimen. NAAT has revolutionized the 
diagnosis of  Chlamydia trachomatis. Urine based screening 
using NAAT has comparable sensitivity and specificity to 
21,22cervical and urethral specimens . 
This study is aimed at determining the prevalence of  
Chlamydia trachomatis infection, and identification of  the 
risk factors associated with genital Chlamydia infection 
among female undergraduates of  the University of  Port 
Harcourt.
MATERIALS AND METHODS
This study was carried out between January and June 2009 at 
the University of  Port Harcourt Teaching Hospital, Port 
Harcourt. Ethical approval was obtained from the relevant 
boards at the University of  Port Harcourt and the University 
of  Port Harcourt Teaching Hospital.
Inclusion criteria were that subjects should be healthy, female 
undergraduates aged between 16 and 30, should not be on 
any antibiotics prior to the collection of  samples, and should 
respond to all or most of  the questions asked in the 
questionnaire. The sample size determined using the Kish 
formula was 400 with prevalence rates of  10.5%, at 95% 
confidence interval, and degree of  accuracy as 0.05.
Informed and written consent was obtained from every 
participant. Those who consented were required to fill in 
questionnaires which detailed the predisposing/risk factors 
associated with Chlamydia trachomatis. They were also 
given vaginal swab for self  administered vaginal swabbing. 
This process was explained to each participant by trained 
clinical students.  All the self  admissible vaginal swabs 
[Genital BBL Culture swab EZ] were quickly transported to 
the laboratory and analyzed by SDA.
RESULTS
Of the 400 students screened, only 44 of  them were positive 
for Chlamydia trachomatis infection. These constitute about 
11% of  the total students screened. From the data obtained, 
students aged between 28 and 30 years have a significantly 
increased chance of  contracting Chlamydia trachomatis 
infection compared to the other age ranges [Table 1], with a p 
2value of  <0.05, X  = 22.081 for linear trend and Odds ratio of  
0.6.
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Table 1: Prevalence of students with Chlamydia trachomatis 
infection according to age range
 Chlamydia trachomatis
No. of Sex Partners  [Positive] Infected [Negative] Not Infected


























The data obtained also showed that about 5.3% of  those with 
no sexual partners at the time of  study were infected 
compared to those with up to four sexual partners who had 
100% infectivity [Table 2], with a p value of  <0.05 using 
2Fischer's test of  exactness, X  = 28.10, RR = 19.00 
(7.32<RR<49.32).
Table 2: Prevalence of students with Chlamydia 
trachomatis infection in relation to number of sexual 
partners
 Chlamydia trachomatis  
Age Range  [Positive] YES  [ Negative] NO
[16-18]  8[33.3%]  16[66.7%]
[19-21]  4[5.3%]  72[94.7%]
[22-24]  12[8.8%]  124[91.2%]











Among the students that judiciously use condom during sexual 
intercourse, none of  the 112 student respondents were infected 
while 39(17.5%) of  those who do not use condom regularly 
were infected. This was statistically significant with a p value of  
2<0.05, X  = 21.99.
The prevalence of  Chlamydia infection among students with 
previous sexually transmitted infections (STI) is shown in 
Table 3, with 15.2% of  subjects with previous STI testing 
positive them compared to 8.8% of  those without a previous 
history of  sexually transmitted disease who were also infected.
2This was statistically significant with a p value of  <0.05, X  = 
4.58.
TABLE 3. Prevalence Chlamydia Trachomatis Infection 





















Table 4 shows the prevalence of  Chlamydia trachomatis infection 
in relation to the number of  sexual partners in the past 90days. 
Subjects with 3 and 4 or more sexual partners had significantly 
2higher rates of  Chlamydia positivity with a p value of  <0.05, X  = 
12.30, RR = 3.99(1.15<RR<10.01).
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DISCUSSION
The present study revealed a prevalence rate of  11% [44 of  the 
400 subjects] for Chlamydia trachomatis infection. Possible 
predictive risk factors gotten as result of  the study include 
increasing age [28 to 30 years], multiple sexual partners, 
inconsistent contraceptive usage, and a past history of  STI. 
The prevalence of  Chlamydia infection in our study exceeds 
that from reported studies, which indicate a prevalence of  
1010% in sexually active adolescent women , considering that 
sexual activity was not an inclusion criterion in our study.
The documented prevalence of  Chlamydia infection differs 
considerably depending on the methodologies for the 
identification leading to different prevalence rates even in 
similar populations. Techniques used in identification 
include antibody detection, antigen detection, culture, and 
nucleic acid amplification. Amplification methods use 
different approaches to achieve the amplification of  low 
copies of  nucleic acid to amounts that can subsequently be 
detected. This method has a better sensitivity than culture and 
allows the detection of  infection in individuals with a low 
20number of  infectious units .
The probable predictive risk factors from the present study are 
5in keeping with those from previous studies; increasing age , 
6 7sexual activity ; past histories of  STI's ; multiple sexual 
8 9partners ; and poor contraceptive usage .
Treatment of  Chlamydial infections, save for being cheap and 
effective, have an added benefit: treatment of  Chlamydial 
in fec t ions  could  de lay  the  spread of  human 
immunodeficiency virus [HIV] as Chlamydia trachomatis 
17infections are known to increase the risk for HIV infection , 
with women infected with Chlamydia up to five times more 
17likely to become infected with HIV  because Chlamydia 
induces inflammation which results in an increased 
recruitment of  CD  lymphocytes into the genital tract leading 4
to an increase in HIV targets and an increased HIV 
replication is thought to contribute to enhanced 
17transmission .
The biggest challenge to the treatment and control of  
Chlamydial disease is that as many as 70 to 80% of  women 
infected with Chlamydia trachomatis are asymptomatic but 
still contagious, resulting in a large reservoir of  unrecognized, 
infected individuals who are capable of  transmitting the 
infection to sexual partners. Contributing to this challenge is 
the fact that immunity following infection is thought to be 
type specific, not organism specific and only partially 
18protective ; hence, recurrent infections are common. 
Evidence suggests that the risk of  developing sequelae such as 
ectopic pregnancy or infertility increases with each successive 
19episode of  infection .
Considering that all subjects that were positive for Chlamydia 
trachomatis were asymptomatic and the morbidity caused by 
Chlamydia trachomatis infection, the relevance of  routine 
screening for Chlamydia trachomatis is strongly highlighted 
as treatment is cheap and effective, while the attendant 
morbidity resulting from delayed diagnosis is more difficult to 
manage and associated with severe sequelae. Screening 
should be cheap, readily accessible with acceptable degrees of  
sensitivity and specificity, and non-invasive.
The SDA provides high specificity and sensitivity in the 
20diagnosis of  Chlamydia trachomatis infection , allows for 
the use of  urine and vaginal swabs, with urine based screening 
having comparable sensitivity and specificity to cervical and 
12, 21,22urethral specimens . Though various questions have been 
asked concerning the cost-effectiveness and eligibility of  
23routine screening , age-based routine screening provides the 
greatest cost-saving strategy to identify those infected with 
24,26Chlamydia trachomatis , considering the economic 
importance of  long term sequelae from infection.
The paucity of  data on the prevalence of  Chlamydia 
trachomatis infection in Nigeria using SDA is due primarily 
to the lack of  policy on routine screening for Chlamydia 
trachomatis using NAAT, unlike in the first world where it is 
26done for populations where prevalence exceeds 3% . There is 
an obvious need to assess the trend of  STI including genital 
Chlamydia trachomatis infection among young, 
asymptomatic, non-pregnant females.  
CONCLUSION
There is an urgent need for a national policy on routine 
screening for Chlamydia trachomatis as treatment is cheap 
and effective, while the attendant morbidity resulting from 
delayed diagnosis is more difficult to manage and associated 
with severe sequelae.
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